Loading bill…
Loading bill…
Bill Tracker · Kentucky
An Act relating to ibogaine research in the Commonwealth
Vetoed 13 Apr 2026; veto overridden 14 Apr 2026 (Senate 31–6, House 77–18); Acts Chapter 158.
Summary (from PoliPsy)
Create new sections of KRS Chapter 218A to define terms; establish the ibogaine research and intellectual property fund to be administered by the Department of Agriculture for the purpose of allowing the department to enter a public-private partnership with a drug developer to conduct a clinical drug development trial or trials related to the use of ibogaine for the treatment of opioid use disorder, co-occurring substance use disorder, or any other neurological or mental health condition for which ibogaine demonstrates efficacy; establish requirements for the department related to how it contracts with a drug developer related to ibogaine research and intellectual property; appropriate $21 million from the opioid abatement trust fund to the ibogaine research and intellectual property development fund in fiscal year 2026-2027 and in fiscal year 2027-2028; APPROPRIATION; EMERGENCY.
The full bill text and every version are kept by the legislature. We link to it rather than copy it so readers always see the current version.
Read the full bill textSource: apps.legislature.ky.gov
Passed
Passed
Signed into Law
Enrolled (Passed Both Chambers)
Enrolled (Passed Both Chambers)
Override
Referred
Override
Referred
Vetoed
Enrolled (Passed Both Chambers)
Enrolled (Passed Both Chambers)
Committee Report
Referred
Referred
Engrossed (Passed One Chamber)
Committee Report
Referred
Referred
Introduced